Jonathan Oakman, PhD, CPsych
- 4Articles
- 14.8KReads1
- 2002–2010Active
- 10Collaborators
- 112Citations2
About
Jonathan Oakman, PhD, CPsych, has published extensively on the treatment of anxiety-related conditions, including phobic disorders and impulse-control disorders, with a focus on pharmacological interventions. His work includes clinical trials investigating medications such as olanzapine, nefazodone, and topiramate for conditions like trichotillomania, generalized social phobia, and SSRI-induced weight gain in anxiety disorders. Oakman's research contributions span from 2002 to 2010 and have appeared in Psychiatrist.com publications.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
